|
| E 1210 (pharMaceutical) Basic information |
Product Name: | E 1210 (pharMaceutical) | Synonyms: | E 1210;E 1210 (pharMaceutical);3-[3-[[4-(pyridin-2-yloxymethyl)phenyl]methyl]-1,2-oxazol-5-yl]pyridin-2-amine;APX 001A;APX001
(APX 001A;2-Pyridinamine, 3-[3-[[4-[(2-pyridinyloxy)methyl]phenyl]methyl]-5-isoxazolyl]-;E1210 ( APX001A);APX001A Tosylate | CAS: | 936339-60-5 | MF: | C21H18N4O2 | MW: | 358.39 | EINECS: | | Product Categories: | | Mol File: | 936339-60-5.mol | ![E 1210 (pharMaceutical) Structure](CAS/20180808/GIF/936339-60-5.gif) |
| E 1210 (pharMaceutical) Chemical Properties |
Boiling point | 569.4±45.0 °C(Predicted) | density | 1.263±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO: 100 mg/mL (279.03 mM) | pka | 5.13±0.36(Predicted) |
| E 1210 (pharMaceutical) Usage And Synthesis |
Uses | 3-[3-[[4-[(2-Pyridinyloxy)methyl]phenyl]methyl]-5-isoxazolyl]-2-pyridinamine is a new broad-spectrum antifungal. |
| E 1210 (pharMaceutical) Preparation Products And Raw materials |
|